BASILICA Procedure Prevents Coronary Obstruction From TAVR
BASILICA Procedure Prevents Coronary Obstruction From TAVR
A novel technique has proven preventing coronary artery during transcatheter aortic valve (TAVR), the technique will treatment options for high-risk who need heart valve The findings by at the National Institutes Health (NIH) were published the Journal the College Cardiology: BASILICA Procedure Prevents Cardiovascular June 12, TAVR offers effective and less invasive to open heart surgery. However, this complication has fatal. During TAVR.
Heart valves play an important role in controlling the blood flow to and from the heart. The heart consists of four main types of valves that are tricuspid, pulmonary, mitral, and aortic valves. Prosthetic heart valves are commonly known as artificial valves that implanted in the heart of the patients suffering from the valvular heart disease. Thus, the surging incidence of heart disorders drives the prosthetic heart valve market over the forecast period. There are 3 types of prosthetic heart valve prosthetic aortic valve such as mechanical heart valve, tissue heart valve, and transcatheter heart valve. The aging population and increasing patient population of heart disease are expected to drive demand for prosthetic heart valve-based treatment in the future. For instance, According to the statistics of World Health Organization in 2012, 17. 6 million people died of cardiovascular disease (CVD) worldwide, and proportionally, this accounts for 31. 43% of global mortality. Moreover, The emergence of valve-in-valve procedures serves as a significant market opportunity for the prosthetic heart valve.
Europe accounted majority share (nearly half) in in 2016, Prosthetic Heart Valve owing increased adoption development novel by key players. In addition, rise Prosthetic Heart Valve in among patients & physicians availability advanced rise in availability valves procedures in certain European are key factors have increased adoption advanced valves in region. The Global Prosthetic Valve Market was valued $3, is expected reach $8, growing a CAGR 11. from 2017 2023. The transcatheter heart valve accounted more than share total in 2016.
Comments
Post a Comment